Therapeutic targeting of receptor tyrosine kinases in lung cancer

Author： Choong Nicholas W Ma Patrick C Salgia Ravi

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.3, 2005-06, pp. : 533-559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting tyrosine-kinases in ovarian cancer

By Morotti Matteo Becker Christian M Menada Mario Valenzano Ferrero Simone

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1265-1279

Informa Healthcare

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Current Drug Targets, Vol. 17, Iss. 14, 2016-11 ,pp. : 1687-1703

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4854-4855

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene

Current Drug Targets, Vol. 2, Iss. 1, 2001-01 ,pp. : 41-55

Bentham Science Publishers

Access to resources Recommend Favorite